Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,053 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).
Scherrer AU, Traytel A, Braun DL, Calmy A, Battegay M, Cavassini M, Furrer H, Schmid P, Bernasconi E, Stoeckle M, Kahlert C, Trkola A, Kouyos RD, Tarr P, Marzolini C, Wandeler G, Fellay J, Bucher H, Yerly S, Suter F, Hirsch H, Huber M, Dollenmaier G, Perreau M, Martinetti G, Rauch A, Günthard HF; Swiss HIV Cohort Study (SHCS). Scherrer AU, et al. Among authors: huber m. Int J Epidemiol. 2022 Feb 18;51(1):33-34j. doi: 10.1093/ije/dyab141. Int J Epidemiol. 2022. PMID: 34363666 No abstract available.
Interferon alpha-2a plus ribavirin 1,000/1,200 mg versus interferon alpha-2a plus ribavirin 600 mg for chronic hepatitis C infection in patients on opiate maintenance treatment: an open-label randomized multicenter trial.
Huber M, Weber R, Oppliger R, Vernazza P, Schmid P, Schönbucher P, Bertisch B, Meili D, Renner EL. Huber M, et al. Infection. 2005 Feb;33(1):25-9. doi: 10.1007/s15010-005-4043-2. Infection. 2005. PMID: 15750756 Free article. Clinical Trial.
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Ledergerber B; Swiss HIV Cohort Study. Weber R, et al. Among authors: huber m. HIV Med. 2009 Aug;10(7):407-16. doi: 10.1111/j.1468-1293.2009.00701.x. Epub 2009 May 26. HIV Med. 2009. PMID: 19490174 Free article.
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians.
Huber M, Ledergerber B, Sauter R, Young J, Fehr J, Cusini A, Battegay M, Calmy A, Orasch C, Nicca D, Bernasconi E, Jaccard R, Held L, Weber R; Swiss HIV Cohort Study Group. Huber M, et al. HIV Med. 2012 Aug;13(7):387-97. doi: 10.1111/j.1468-1293.2011.00984.x. Epub 2012 Jan 18. HIV Med. 2012. PMID: 22257025 Free article.
Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
Weber R, Huber M, Battegay M, Stähelin C, Castro Batanjer E, Calmy A, Bregenzer A, Bernasconi E, Schoeni-Affolter F, Ledergerber B; Swiss HIV Cohort Study. Weber R, et al. Among authors: huber m. HIV Med. 2015 Mar;16(3):137-51. doi: 10.1111/hiv.12184. Epub 2014 Aug 15. HIV Med. 2015. PMID: 25124393 Free article.
2,053 results